European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Volume 62, Issue 3, Pages (September 2012)
The PSA Era is not Over for Prostate Cancer
Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Volume 50, Issue 1, Pages (July 2006)
Volume 62, Issue 3, Pages (September 2012)
Volume 65, Issue 3, Pages (March 2014)
Volume 58, Issue 5, Pages (November 2010)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.
Volume 53, Issue 5, Pages (May 2008)
Volume 51, Issue 4, Pages (April 2007)
Prostate Cancer Epidemic in Sight?
European Urology Oncology
Pitfalls of Pathologic Staging in Prostate Cancer
What is New in Hormone Therapy for Prostate Cancer in 2007?
European Urology Oncology
Volume 65, Issue 3, Pages (March 2014)
Volume 67, Issue 3, Pages (March 2015)
Volume 64, Issue 5, Pages (November 2013)
Laurent Boccon-Gibod  European Urology Supplements 
Volume 73, Issue 2, Pages (February 2018)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer  Matthew R. Smith  European Urology Supplements 
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial  Eva Johansson,
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective,
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 74, Issue 4, Pages (October 2018)
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Long-Term Hormonal Therapy: Who Would Benefit?
European Urology Oncology
European Urology Oncology
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial  Martin Nyberg, Jonas.
European Urology Oncology
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
The Cost to Medicare of Bladder Cancer Care
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
European Urology Oncology
European Urology Oncology
Highlighting Unmet Needs: Real Patients, Difficult Choices
European Urology Oncology
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Axel Heidenreich  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

European Urology Oncology Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy  Filip Poelaert, Steven Joniau, Thierry Roumeguère, Filip Ameye, Greet De Coster, Peter Dekuyper, Thierry Quackels, Ben Van Cleynenbreugel, Nancy Van Damme, Elizabeth Van Eycken, Alexander Mottrie, Nicolaas Lumen  European Urology Oncology  DOI: 10.1016/j.euo.2018.05.005 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 The median time to additional treatment in pT3b prostate cancer (seminal vesicle invasion on pathology) after robot-assisted laparoscopic radical prostatectomy was 7 mo. RT=radiotherapy; ADT=androgen deprivation therapy. European Urology Oncology DOI: (10.1016/j.euo.2018.05.005) Copyright © 2018 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.